Sponsored Educational Supplement:  Comparison of Tolerability and Adverse Events Following Treatment with Two GnRH Agonists in Patients with Advanced Prostate Cancer

Sponsored Educational Supplement: Comparison of Tolerability and Adverse Events Following Treatment with Two GnRH Agonists in Patients with Advanced Prostate Cancer


Identification: unj_so13_03
Issue: September-October 2013
Volume: Volume 33 Number 5

Standard: $15.00

Description

Publication of this article is supported by a sponsorship provided by Watson Pharma.

Speaker(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content